- Home
- DSWL vs MREO Comparison
DSWL vs MREO Comparison
Compare DSWL & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSWL | MREO |
|---|---|---|
| Founded | 1987 | 2015 |
| Country | Macau | United Kingdom |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.9M | 52.5M |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | DSWL | MREO |
|---|---|---|
| Price | $3.11 | $0.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 9.2K | ★ 1.3M |
| Earning Date | 11-13-2025 | 05-12-2026 |
| Dividend Yield | ★ 6.73% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,000.00 |
| Revenue This Year | N/A | $6,000.20 |
| Revenue Next Year | N/A | $34.71 |
| P/E Ratio | $4.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $0.20 |
| 52 Week High | $4.48 | $2.94 |
Technical Indicators
Market Signals| Indicator | DSWL | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 37.16 |
| Support Level | $2.79 | $0.32 |
| Resistance Level | $3.40 | $0.42 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 34.62 | 21.62 |
Price Performance
Historical ComparisonAbout DSWL Deswell Industries Inc.
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).